๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Capillary electrophoretic detection of metabolites in the urine of patients receiving hypoglycemic drug therapy

โœ Scribed by Matthew E. Roche; Robert P. Oda; George M. Lawson; Dr. James P. Landers


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
911 KB
Volume
18
Category
Article
ISSN
0173-0835

No coin nor oath required. For personal study only.

โœฆ Synopsis


Capillary electrophoretic detection of metabolites in the urine of patients receiving hypoglycemic drug therapy

Micellar electrokinetic chromatography (MEKC) in tandem with diode array detection (DAD) has been exploited as an analytical method for the separation and detection of sulfonylurea drugs. The ultimate goal is the development of an assay to detect these drugs or their metabolites in urine as a means of diagnosing sulfonylurea drug abuse. Using a spearation buffer consisting of 5 mM borate/5 mM phosphate/75 mM sodium cholate, separation of both the second and third generation sulfonylurea drugs can be achieved. The characteristic absorbance spectra associated with each of the third generation drugs, glipizide and glyburide, allow for their identification in mixtures. Coinjection of glyburide, its primary metabolite, hydroxy glyburide, and glipizide demonstrated that the metabolite was resolved from the parent drug but shared its absorbance spectral properties. MEKC analysis of a series of solid phaseextracted urine samples from patients prescribed glipizide or glyburide, as well as from control patients not ingesting the drug, showed that the parent compounds were difficult to detect in the urine. However, the use of DAD allowed for detection of metabolites in the urine of these patients. With glyburide patients, only primary metabolites were detected, while urine from patients on glipizide showed a series of peaks whose absorbance spectra was consistent with the presence of both primary and secondary metabolites. In addition, the intensity of the metabolite peaks corresponded reasonably well with the respective dose and in vivo time interval associated with the urine collection, This study shows that MEKC with DAD has potential for further exploration as a clinical assay for detecting surreptitious abuse of sulfonylurea drugs.


๐Ÿ“œ SIMILAR VOLUMES


Stability and inactivation of mutagenic
โœ D. K. Monteith; T. H. Connor; J. A. Benvenuto; E. J. Fairchild; J. C. Theiss ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 886 KB

Urine samples from patients administered mutagenic antineoplastic drugs are mutagenic in the Ames assay, and hence may pose a genotoxic hazard to hospital personnel or family members caring for the patient. The urine samples in the present study were tested for mutagenicity in several strains of Sal